A Canadian, Multicentre Study Comparing the Efficacy of a Levonorgestrel-releasing Intrauterine System to an Oral Contraceptive in Women With Idiopathic Menorrhagia

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 4, 2009, Pages 340-347

  Endrikat, Jan ^a,b   Shapiro, Heather ^c   Lukkari Lax, Eeva ^d   Kunz, Michael ^e   Schmidt, Werner ^d   Fortier, Michel ^f  

^a Bayer Inc   (Canada)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d Bayer Schering Pharma Oy   (Finland)

^e BAYER PHARMA AG   (Germany)

^f Clinique de Recherche en Sante des Femmes   (Canada)

Author keywords

Idiopathic menorrhagia; Levonorgestrel releasing intrauterine system; Oral contraceptive

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; HEMOGLOBIN; LEVONORGESTREL; CONTRACEPTIVE AGENT; DRUG DERIVATIVE; ESTROGEN; ETHINYLESTRADIOL; NORETHISTERONE; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IDIOPATHIC MENORRHAGIA; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; INTRAUTERINE CONTRACEPTIVE DEVICE;

ADULT; CANADA; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HEMOGLOBINS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; NORETHINDRONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 68049083517     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34151-2     Document Type: Article

References (21)

1. SperoffL., Fritz M. Clinical gynecologic endocrinology and infertility 2004, 575-593. Lippincott Williams & Wilkins, Baltimore, MD. 7th ed.
2. Farquar C. Management of dysfunctional uterine bleeding. Drugs 1992, 44:578-5784.
3. Mansour D. Modern management of abnormal uterine bleeding-the levonorgestrel intra-uterine system. Best Pract Res Clin Obstet Gynaecol 2007, 21:1007-1021.
4. Tang G.W.K., Lo S.S.T. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995, 231-235.
5. Irvine G.A., Campbell-Brown M.B., Lumsden M.A., Heikkila A., Walker J.J., Cameron I.T. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998, 105:592-598.
6. Scholten P.C., Christiaens G.C.M.L., Haspels A.A. Treatment of menorrhagia by intrauterine administration of levonorgestrel. The levonorgestrel IUD: clinical performance and impact on menstruation 1989, 47-55. University of Utrecht, Utrecht.
7. Luukkainen T., Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995, 52:269-276.
8. Rauramo I., Elo I., Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004, 104(6):1314-1321.
9. Reid P., Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005, 112(8):1121-1125.
10. Xiao B., Wu S.C., Chong J., Zeng T., Han L.H., Luukkainen T. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 2003, 79(4):963-969.
11. Chrisman C., Ribeiro P., Dalton V.K. The levonorgestrel-releasing intrauterine system: An updated review of the contraceptive and noncontraceptive uses. Clin Obstet Gynecol 2007, 50:886-897.
12. Crosignani P.G., Vercellini P., Mosconi P., Oldani S., Cortesi I., De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine Bleeding. Obstet Gynecol 1997, 90:257-263.
13. Milsom I., Andersson K., Andersch B., Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991, 164:879-883.
14. Higham J., O'Brien P.M.S., Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990, 97:734-739.
15. Ruta D.A., Garratt A.M., Chadha Y.C., Flett G.M., Hall M.H., Russell I.T. Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status?. Qual Life Res 1995, 4:33-40.
16. Barrington J.W., Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997, 104(5):614-616.
17. Hurskainen R., Paavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004 Dec, 16:487-489.
18. Istre O., Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001, 76:304-309.
19. Hurskainen R., Teperi J., Rissanen P., Aalto A.M., Grenman S., Kivelä A., et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004, 24(291):1503-1504.
20. Andersson K., Batar I., Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992, 46:575-584.
21. Belhadj H., Sivin I., Diaz S., Pavez M., Tejada A.S., Brache V., et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986, 34:261-267.